Kelden Richardson The Australasian Society for Immunology 2017 Annual Scientific Meeting

Abstracts this author is presenting:

• Mechanisms behind elotuzumab and lenalidomide dual therapy in multiple myeloma — Workshop 8: Vaccines and Immunotherapies